Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens.

García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE, Blair HC.

J Biol Chem. 2005 Apr 8;280(14):13720-7. Epub 2005 Jan 11.

3.

[Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].

Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.

Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2102-6. Chinese.

PMID:
15730627
4.

Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis.

Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K.

J Biol Chem. 2004 Apr 2;279(14):13555-63. Epub 2004 Jan 16.

5.
6.

Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.

Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.

Blood. 2005 Apr 1;105(7):2963-9. Epub 2004 Dec 7.

7.

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.

Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O.

Blood. 2003 May 1;101(9):3451-9. Epub 2003 Jan 2.

8.

Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.

Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M.

J Cell Biochem. 2004 May 15;92(2):285-95.

PMID:
15108355
10.

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.

Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.

PMID:
15752732
11.

RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.

Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.

Bone. 2006 May;38(5):678-85. Epub 2005 Nov 23.

PMID:
16309985
12.

The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T.

Arthritis Rheum. 2004 Mar;50(3):794-804.

13.

MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival.

Okamatsu Y, Kim D, Battaglino R, Sasaki H, Späte U, Stashenko P.

J Immunol. 2004 Aug 1;173(3):2084-90.

14.

TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.

Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P.

Blood. 2004 Oct 1;104(7):2044-50. Epub 2004 Jun 22.

15.

Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.

Kostelac D, Rechkemmer G, Briviba K.

J Agric Food Chem. 2003 Dec 17;51(26):7632-5.

PMID:
14664520
16.

Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.

Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.

Life Sci. 2007 Mar 13;80(14):1311-8. Epub 2007 Jan 23.

PMID:
17306833
17.

RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.

Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM.

J Bone Miner Res. 2005 Jan;20(1):107-16. Epub 2004 Oct 25.

18.

Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.

Ni YD, Hong WJ, Zhou YC, Grossmann R, Zhao RQ.

Steroids. 2010 Mar;75(3):245-51. doi: 10.1016/j.steroids.2009.12.009. Epub 2010 Jan 4.

PMID:
20043933
19.

Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.

Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E.

J Cell Physiol. 2009 Jul;220(1):35-44. doi: 10.1002/jcp.21724.

PMID:
19347870
20.

Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.

Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N, Takahashi N.

J Biol Chem. 2005 Mar 25;280(12):11395-403. Epub 2005 Jan 12.

Supplemental Content

Support Center